Platelet-type Von Willebrand disease: Three decades in the life of a rare bleeding disorder

Blood Reviews

Volumn 25, Issue 4, 2011, Pages 147-153

  Othman, Maha ^a,b  

^a QUEEN S UNIVERSITY   (Canada)

^b LAURENTIAN UNIVERSITY   (Canada)

Author keywords

Platelet function defects; Type 2B VWD

Indexed keywords

FIBRINOGEN RECEPTOR; GLYCOPROTEIN IB ALPHA; GLYCOPROTEIN IB IX V RECEPTOR COMPLEX; MEMBRANE PROTEIN; POLYPEPTIDE; RISTOCETIN; THROMBOCYTE CONCENTRATE; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING SITE; BLEEDING DISORDER; CARBOXY TERMINAL SEQUENCE; CONSENSUS SEQUENCE; CRYOPRECIPITATE; DISEASE CLASSIFICATION; FLOW CYTOMETRY; GAIN OF FUNCTION MUTATION; GENE; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; GENETIC POLYMORPHISM; GLYCOPROTEIN IB ALPHA GENE; HUMAN; LABORATORY TEST; MOLECULAR WEIGHT; NOMENCLATURE; NONHUMAN; PLATELET TYPE VON WILLEBRAND DISEASE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; RARE DISEASE; REGISTER; RISTOCETIN INDUCED PLATELET AGGLUTINATION TEST; RISTOCETIN INDUCED PLATELET AGGREGATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGLUTINATION; THROMBOCYTE AGGREGATION; THROMBOCYTOPENIA; VARIABLE NUMBER OF TANDEM REPEAT; VON WILLEBRAND DISEASE;

ANIMALS; BLOOD PLATELETS; DATABASES, FACTUAL; DISEASE MODELS, ANIMAL; HUMANS; MICE; MICE, TRANSGENIC; PROTEIN BINDING; RECEPTORS, CELL SURFACE; REGISTRIES; VON WILLEBRAND DISEASES; VON WILLEBRAND FACTOR;

EID: 79957995268     PISSN: 0268960X     EISSN: 15321681     Source Type: Journal    
DOI: 10.1016/j.blre.2011.03.003     Document Type: Article

References (58)

1. Weiss H.J., Meyer D., Rabinowitz R., Pietu G., Girma J.P., Vicic W.J., et al. Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers. N Engl J Med 1982, 306:326-333.
2. Miller J.L., Castella A. Platelet-type von Willebrand's disease: characterization of a new bleeding disorder. Blood 1982, 60:790-794.
3. Miller J.L., Kupinski J.M., Castella A., Ruggeri Z.M. von Willebrand factor binds to platelets and induces aggregation in platelet-type but not type IIB von Willebrand disease. J Clin Invest 1983, 72:1532-1542.
4. Lopez J.A., Chung D.W., Fujikawa K., Hagen F.S., Papayannopoulou T., Roth G.J. Cloning of the alpha chain of human platelet glycoprotein Ib: a transmembrane protein with homology to leucine-rich alpha 2-glycoprotein. Proc Natl Acad Sci U S A 1987, 84:5615-5619.
5. Lopez J.A., Chung D.W., Fujikawa K., Hagen F.S., Davie E.W., Roth G.J. The alpha and beta chains of human platelet glycoprotein Ib are both transmembrane proteins containing a leucine-rich amino acid sequence. Proc Natl Acad Sci U S A 1988, 85:2135-2139.
6. Hickey M.J., Hagen F.S., Yagi M., Roth G.J. Human platelet glycoprotein V: characterization of the polypeptide and the related Ib-V-IX receptor system of adhesive, leucine-rich glycoproteins. Proc Natl Acad Sci U S A 1993, 90:8327-8331.
7. Luo S.Z., Mo X., Afshar-Kharghan V., Srinivasan S., Lopez J.A., Li R. Glycoprotein Ibalpha forms disulfide bonds with 2 glycoprotein Ibbeta subunits in the resting platelet. Blood 2007, 109:603-609.
8. Vicente V., Houghten R.A., Ruggeri Z.M. Identification of a site in the alpha chain of platelet glycoprotein Ib that participates in von Willebrand factor binding. J Biol Chem 1990, 265:274-280.
9. Murata M., Ware J., Ruggeri Z.M. Site-directed mutagenesis of a soluble recombinant fragment of platelet glycoprotein Ib alpha demonstrating negatively charged residues involved in von Willebrand factor binding. J Biol Chem 1991, 266:15474-15480.
10. Andrews R.K., Du X., Berndt M.C. The 14-3-3zeta-GPIb-IX-V complex as an antiplatelet target. Drug News Perspect 2007, 20:285-292.
11. Andrews R.K., Lopez J.A., Berndt M.C. Molecular mechanisms of platelet adhesion and activation. Int J Biochem Cell Biol 1997, 29:91-105.
12. Lopez J.A., Dong J.F. Structure and function of the glycoprotein Ib-IX-V complex. Curr Opin Hematol 1997, 4:323-329.
13. Dong J.F., Li C.Q., Lopez J.A. Tyrosine sulfation of the glycoprotein Ib-IX complex: identification of sulfated residues and effect on ligand binding. Biochemistry 1994, 33:13946-13953.
14. Shen Y., Dong J.F., Romo G.M., Arceneaux W., Aprico A., Gardiner E.E., et al. Functional analysis of the C-terminal flanking sequence of platelet glycoprotein Ib alpha using canine-human chimeras. Blood 2002, 99:145-150.
15. Shen Y., Romo G.M., Dong J.F., Schade A., McIntire L.V., Kenny D., et al. Requirement of leucine-rich repeats of glycoprotein (GP) Ibalpha for shear-dependent and static binding of von Willebrand factor to the platelet membrane GP Ib-IX-V complex. Blood 2000, 95:903-910.
16. Cauwenberghs N., Vanhoorelbeke K., Vauterin S., Deckmyn H. Structural determinants within platelet glycoprotein Ibalpha involved in its binding to von Willebrand factor. Platelets 2000, 11:373-378.
17. Andrews R.K., Shen Y., Gardiner E.E., Dong J.F., Lopez J.A., Berndt M.C. The glycoprotein Ib-IX-V complex in platelet adhesion and signaling. Thromb Haemost 1999, 82:357-364.
18. Favaloro E.J. Laboratory assessment as a critical component of the appropriate diagnosis and sub-classification of von Willebrand's disease. Blood Rev 1999, 13:185-204.
19. Miller J.L. Platelet-type von Willebrand disease. Thromb Haemost 1996, 75:865-869.
20. Nurden A.T. Qualitative disorders of platelets and megakaryocytes. J Thromb Haemost 2005, 3:1773-1782.
21. Favaloro E.J. 2B or not 2B? Differential identification of type 2B, versus pseudo-von Willebrand disease. Br J Haematol 2006, 135:141-142. [author reply 3].
22. Favaloro E.J. Phenotypic identification of platelet-type von Willebrand disease and its discrimination from type 2B von Willebrand disease: a question of 2B or not 2B? A story of nonidentical twins? Or two sides of a multidenominational or multifaceted primary-hemostasis coin?. Semin Thromb Hemost 2008, 34:113-127.
23. Favaloro E.J., Patterson D., Denholm A., Mead S., Gilbert A., Collins A., et al. Differential identification of a rare form of platelet-type (pseudo-) von Willebrand disease (VWD) from Type 2B VWD using a simplified ristocetin-induced-platelet-agglutination mixing assay and confirmed by genetic analysis. Br J Haematol 2007, 139:623-626.
24. Whalley I.N., Perry D.J. 2B or not 2B? Differential identification of Type 2B, versus pseudo-,von Willebrand disease. Br J Haematol 2007, 136:345. [author reply -6].
25. Othman M., Lillicrap D. Distinguishing between non-identical twins: platelet type and type 2B von Willebrand disease. Br J Haematol 2007, 138:665-666.
26. Othman M. Platelet-type von Willebrand disease and type 2B von Willebrand disease: a story of nonidentical twins when two different genetic abnormalities evolve into similar phenotypes. Semin Thromb Hemost 2007, 33:780-786.
27. Othman M. Differential identification of PT-VWD from type 2B VWD and GP1BA nomenclature issues. Br J Haematol 2008, 142:312-314. [author reply 4-5].
28. Othman M., Hamilton A. Platelet-type von Willebrand disease: results of a worldwide survey from the Canadian PT-VWD project. Acta Haematol 2010, 123:126-128.
29. Enayat M.S., Guilliatt A.M., Lester W., Wilde J.T., Williams M.D., Hill F.G. Distinguishing between type 2B and pseudo-von Willebrand disease and its clinical importance. Br J Haematol 2006, 133:664-666.
30. Franchini M., Montagnana M., Lippi G. Clinical, laboratory and therapeutic aspects of platelet-type von Willebrand disease. Int J Lab Hematol 2008, 30:91-94.
31. Miller J.L., Boselli B.D., Kupinski J.M. In vivo interaction of von Willebrand factor with platelets following cryoprecipitate transfusion in platelet-type von Willebrand's disease. Blood 1984, 63:226-230.
32. Frontroth J.P., Hepner M., Sciuccati G., Feliu Torres A., Pieroni G., Bonduel M. Prospective study of low-dose ristocetin-induced platelet aggregation to identify type 2B von Willebrand disease (VWD) and platelet-type VWD in children. Thromb Haemost 2010, 104.
33. Giannini S., Cecchetti L., Mezzasoma A.M., Gresele P. Diagnosis of platelet-type von Willebrand disease by flow cytometry. Haematologica 2010, 95:1021-1024.
34. Ware J., Russell S., Ruggeri Z.M. Cloning of the murine platelet glycoprotein Ibalpha gene highlighting species-specific platelet adhesion. Blood Cells Mol Dis 1997, 23:292-301.
35. Kaski S., Kekomaki R., Partanen J. Systematic screening for genetic polymorphism in human platelet glycoprotein Ibalpha. Immunogenetics 1996, 44:170-176.
36. Afshar-Kharghan V., Li C.Q., Khoshnevis-Asl M., Lopez J.A. Kozak sequence polymorphism of the glycoprotein (GP) Ibalpha gene is a major determinant of the plasma membrane levels of the platelet GP Ib-IX-V complex. Blood 1999, 94:186-191.
37. Corral J., Gonzalez-Conejero R., Lozano M.L., Rivera J., Vicente V. New alleles of the platelet glycoprotein Ibalpha gene. Br J Haematol 1998, 103:997-1003.
38. Ishida F., Ito T., Takei M., Shimodaira S., Kitano K., Kiyosawa K. Genetic linkage of Kozak sequence polymorphism of the platelet glycoprotein Ib alpha with human platelet antigen-2 and variable number of tandem repeats polymorphism, and its relationship with coronary artery disease. Br J Haematol 2000, 111:1247-1249.
39. Matsubara Y., Murata M., Moriki T., Yokoyama K., Watanabe N., Nakajima H., et al. A novel polymorphism, 70Leu/Phe, disrupts a consensus Leu residue within the leucine-rich repeat sequence of platelet glycoprotein Ibalpha. Thromb Haemost 2002, 87:867-872.
40. Kuijpers R.W., Faber N.M., Cuypers H.T., Ouwehand W.H., von dem Borne A.E. NH2-terminal globular domain of human platelet glycoprotein Ib alpha has a methionine 145/threonine145 amino acid polymorphism, which is associated with the HPA-2 (Ko) alloantigens. J Clin Invest 1992, 89:381-384.
41. Aramaki K.M., Reiner A.P. A novel isoform of platelet glycoprotein Ib alpha is prevalent in African Americans. Am J Hematol 1999, 60:77-79.
42. Lopez J.A., Ludwig E.H., McCarthy B.J. Polymorphism of human glycoprotein Ib alpha results from a variable number of tandem repeats of a 13-amino acid sequence in the mucin-like macroglycopeptide region. Structure/function implications. J Biol Chem 1992, 267:10055-10061.
43. Miller J.L., Cunningham D., Lyle V.A., Finch C.N. Mutation in the gene encoding the alpha chain of platelet glycoprotein Ib in platelet-type von Willebrand disease. Proc Natl Acad Sci U S A 1991, 88:4761-4765.
44. Russell S.D., Roth G.J. Pseudo-von Willebrand disease: a mutation in the platelet glycoprotein Ib alpha gene associated with a hyperactive surface receptor. Blood 1993, 81:1787-1791.
45. Takahashi H., Murata M., Moriki T., Anbo H., Furukawa T., Nikkuni K., et al. Substitution of Val for Met at residue 239 of platelet glycoprotein Ib alpha in Japanese patients with platelet-type von Willebrand disease. Blood 1995, 85:727-733.
46. Kunishima S., Heaton D.C., Naoe T., Hickton C., Mizuno S., Saito H., et al. De novo mutation of the platelet glycoprotein Ib alpha gene in a patient with pseudo-von Willebrand disease. Blood Coagul Fibrinolysis 1997, 8:311-315.
47. Huizinga E.G., Tsuji S., Romijn R.A., Schiphorst M.E., de Groot P.G., Sixma J.J., et al. Structures of glycoprotein Ibalpha and its complex with von Willebrand factor A1 domain. Science 2002, 297:1176-1179.
48. Murata M., Russell S.R., Ruggeri Z.M., Ware J. Expression of the phenotypic abnormality of platelet-type von Willebrand disease in a recombinant glycoprotein Ib alpha fragment. J Clin Invest 1993, 91:2133-2137.
49. Moriki T., Murata M., Kitaguchi T., Anbo H., Handa M., Watanabe K., et al. Expression and functional characterization of an abnormal platelet membrane glycoprotein Ib alpha (Met239->Val) reported in patients with platelet-type von Willebrand disease. Blood 1997, 90:698-705.
50. Matsubara Y., Murata M., Sugita K., Ikeda Y. Identification of a novel point mutation in platelet glycoprotein Ibalpha, Gly to Ser at residue 233, in a Japanese family with platelet-type von Willebrand disease. J Thromb Haemost 2003, 1:2198-2205.
51. Nurden P., Lanza F., Bonnafous-Faurie C., Nurden A. A second report of platelet-type von Willebrand disease with a Gly233Ser mutation in the GPIBA gene. Thromb Haemost 2007, 97:319-321.
52. Othman M., Notley C., Lavender F.L., White H., Byrne C.D., Lillicrap D., et al. Identification and functional characterization of a novel 27-bp deletion in the macroglycopeptide-coding region of the GPIBA gene resulting in platelet-type von Willebrand disease. Blood 2005, 105:4330-4336.
53. Uff S., Clemetson J.M., Harrison T., Clemetson K.J., Emsley J. Crystal structure of the platelet glycoprotein Ib(alpha) N-terminal domain reveals an unmasking mechanism for receptor activation. J Biol Chem 2002, 277:35657-35663.
54. Dumas J.J., Kumar R., McDonagh T., Sullivan F., Stahl M.L., Somers W.S., et al. Crystal structure of the wild-type von Willebrand factor A1-glycoprotein Ibalpha complex reveals conformation differences with a complex bearing von Willebrand disease mutations. J Biol Chem 2004, 279:23327-23334.
55. Guerrero J.A., Kyei M., Russell S., Liu J., Gartner T.K., Storrie B., et al. Visualizing the von Willebrand factor/glycoprotein Ib-IX axis with a platelet-type von Willebrand disease mutation. Blood 2009, 114:5541-5546.
56. Suva L.J., Hartman E., Dilley J.D., Russell S., Akel N.S., Skinner R.A., et al. Platelet dysfunction and a high bone mass phenotype in a murine model of platelet-type von Willebrand disease. Am J Pathol 2008, 172:430-439.
57. Sadler J.E., Budde U., Eikenboom J.C., Favaloro E.J., Hill F.G., Holmberg L., et al. Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor. J Thromb Haemost 2006, 4:2103-2114.
58. Hamilton A., Ozelo M., Leggo J., Notley C., Brown H., Frontroth J.P., et al. Frequency of Platelet type versus Type 2B von Willebrand Disease. An international registry-based study. Thromb Haemost 2011, 105:501-508.